About myAMDteam
Powered By
Below is a listing of treatments and therapies for AMD. Click on one to read more information or connect with others currently using it.
Overview
Ahzantive is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD). It’s also indicated for macular edema following retinal vein…
Overview
Avastin is approved by the U.S. Food and Drug Administration (FDA) for treating several types of cancer. It is sometimes prescribed off-label for treating age-related macular degeneration (AMD). Avastin is also…
Overview
Beovu is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD). This medication is typically prescribed to treat vision loss caused…
Overview
Enzeevu is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD). It is prescribed for individuals with AMD to slow vision loss…
Overview
Eylea is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD). It is for individuals who have abnormal blood vessel growth under…
Overview
Izervay is approved by the U.S. Food and Drug Administration (FDA) for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Izervay is also known by its drug name…
Overview
Lucentis is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD). It is also indicated for macular edema following retinal vein…
Overview
Syfovre is approved by the U.S. Food and Drug Administration (FDA) for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Syfovre is also known by its drug name…
Overview
Vabysmo is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD). It’s prescribed for people who’ve developed abnormal blood vessels…
Overview
Yesafili is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD), as well as macular edema following retinal vein occlusion…
Sign up for free today!
Continue with Facebook
Sign up with your email
Your privacy is our priority. By continuing, you accept our
Terms of Use, and our
Health Data and
Privacy policies.
